On Monday (September 22), US President Donald Trump proposed a link between the use of over -the -counter painkillers during pregnancy and the development of autism, which claims that many medical experts question.
“We’ll take if Tylenol is not good. I’ll say it. It’s not good,” Trump said. “For this reason, they strongly recommend that women limit the use of Tylenol during pregnancy, unless medically necessary.”
He added, “You shouldn’t give a child to Tylenol every time he gets a shot.”
The president also mentioned leucovorin, a form of folic acid, as a potential treatment of autism symptoms during the White House event.
FDA involvement and leukovorin approval
Trump said the FDA would tell doctors that the use of Tylenol during pregnancy was associated with an increased risk of autism, even if it did not provide supporting evidence.
The FDA has recently approved the version of leukovorin formed by GSK for use in a rare metabolic disorder called cerebral folate deficiencies, which may lead to neurological symptoms observed in some cases of autism.
According to the FDA, approval followed by the review of leukovorin use in 40 patients with disorder.
Industry
Tylenol is produced by Kenva, in 2023 he started from Johnson & Johnson. Generally, general versions of acetaminophene are also available.
The company spokesman said on Monday, “We disagree with the proposal of a legacy that is not based on science.”
The context of public health
Trump’s administration, managed by Minister of Health Robert F. Kennedy Jr. And its re -movement of healthy America was under pressure to deal with the increase in cases of autism in the US.
Administration also makes wider changes in public health agencies, including the Center for Control and Prevention of Diseases, where the immunization panel recently changed Covid-19 and other instructions for vaccines. Critics noticed that the panel is employed with characters who were historically critical to vaccines.
(Tagstotranslate) Tylenol
